CGMP Deviations: use of an unapproved raw material
FDA MedWatch published a clinical safety alert in Pharmacology on 15 Apr 2026. The item focuses on CLONIDINE TRANSDERMAL SYSTEM: Class II recall update. Open the detail page to review the full original feed content.